UVA has pioneered an innovative new use for telemedicine in the battle against COVID-19, adapting it to improve patient care, conserve PPE and prevent infections.
New approaches under study at UVA could revolutionize treatment for conditions from Alzheimer’s to epilepsy to brain tumors – and even help repair the devastating damage caused by stroke.
Jim Galloway and Timothy Wilson last week became the fourth and fifth UVA faculty members elected to the National Academy of Sciences for their pathbreaking research.